Immunoglobulins as an alternative strategy of psychopharmacological treatment of children with autistic disorder

Neuropsychopharmacology

Volumn 28, Issue 5, 2003, Pages 1014-1015

  Niederhofer, Helmut ^a   Staffen, W ^a   Mair, A ^a  

^a Christian Doppler Klinik   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; AUTISM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; LETTER; MALE; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT;

ADOLESCENT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; IMMUNOGLOBULINS; MALE;

EID: 0038050713     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300130     Document Type: Letter

References (15)

1. Achiron A, Pras E, Gilad R, Ziv I, Mandel M, Gordon CR et al (1992). Open controlled trial of intravenous immune globulin in relapsing-remitting multiple sclerosis. Arch Neurol 49: 1233-1236.
2. Amman MG, Singh NN, Stewart AW, Field CL (1985a). The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J MentDef 39: 485-491.
3. Amman MG, Singh NN, Stewart AW, Field CJ (1985b). Psycho-metric characteristics of the aberrant behavior checklist. Am J MentDef 99: 492-502.
4. Birmaher B, Quintana H, Greenhill LL (1988). Methylphenidate treatment of hyperactive autistic children. J Am Acad Child Adol Psychiatry 27: 248-251.
5. Campbell M, Adams P, Perry R, Speneer RK, Overall JE (1985). Tardive and withdrawal dyskinesia in autistic children: a prospective study. Psychopharmacol Bull 24: 251-255.
6. Campbell M, Cohen IL, Anderson LT (1951).Pharmacotherapy for autistic children, a summary of research. Can J Psychiatry 26: 265-273.
7. Campbell M, Fish B, David R, Shapiro T, Collins P, Koh C (1972). Response to triiodothyronine and dextroamphetamine: a study of preschool schizophrenic children. J Autism Child Schizophr 2: 943-955.
8. Cosi V, Lombardi M, Piccolo G, Erbetta A (1991). Treatment of myasthenia gravis with high dose intravenous immunoglobulin. ActaNeurolScand 84: 8184.
9. Fudenberg HH, Singh VK, Emerson D (1987). Immunodiagnosis and immunotherapy in autistic children. J Neuroimmunol 16: 58-59.
10. Gross-Tsur V, Shalev RS, Kazir E, Engelhard D, Amir N (1993).Intravenous high-dose gamma globulins for intractable child-hood epilepsy. ActaNeurolScand 88: 204-209.
11. Jaselskis CA, Cook EH, Fleteher KE, Leventhal BL (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. J ClinPsychopharmacol 5: 322-327.
12. Perry R, Campbell M, Adams P, Lyneh N, Speneer EK (1959). Long-term efficacy of haloperidol in autistic children: contin-uous versus discontinuous drug administration. J Am Acad Child Adol Psychiatry 25: 57-92.
13. Plioplys AV (1998). Intravenous immunoglobulin treatment of children with autism. J Child Neurol 13: 79-82.
14. Plioplys AV, Greaves A, Kazemi K (1994). Immunoglobulin reactivity in autism and Rett Syndrome. Dev Brain Dysfunct 7: 12-16.
15. Van Doom PA, Brand A, Strengers PFW (1990). High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double blind placebo-con-trolled cross over study. Neurology 40: 209-212.